{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:35:52Z","timestamp":1785872152916,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.euo.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T16:38:59Z","timestamp":1555951139000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies"],"prefix":"10.1016","volume":"4","author":[{"given":"Evgeny","family":"Yakirevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Madison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Fridman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamlal","family":"Mangray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedito A.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siraj M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2019.04.002_bib0185","series-title":"WHO classification of tumors of the urinary system and male genital organs","first-page":"54","article-title":"Mesenchymal tumors occurring mainly children","author":"Argani","year":"2016"},{"key":"10.1016\/j.euo.2019.04.002_bib0190","series-title":"WHO classification of tumors of the urinary system and male genital organs","first-page":"59","article-title":"Mesenchymal tumors occurring mainly in adults","author":"Martignoni","year":"2016"},{"key":"10.1016\/j.euo.2019.04.002_bib0195","doi-asserted-by":"crossref","first-page":"505.e15","DOI":"10.1016\/j.urolonc.2015.07.022","article-title":"Clinicopathologic characteristics and survival for adult renal sarcoma: a population-based study","volume":"33","author":"Moreira","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2019.04.002_bib0200","series-title":"Tumors of uncertain differentiation","first-page":"194","article-title":"WHO classification of tumors of soft tissue and bone","author":"Fletcher","year":"2013"},{"key":"10.1016\/j.euo.2019.04.002_bib0205","series-title":"WHO classification of tumors of soft tissue and bone","first-page":"236","article-title":"Undifferentiated\/unclassified sarcomas","author":"Fletcher","year":"2013"},{"key":"10.1016\/j.euo.2019.04.002_bib0210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000478-200203000-00005","article-title":"Primary Ewing's sarcoma\/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases","volume":"26","author":"Jimenez","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2019.04.002_bib0215","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00000478-200008000-00006","article-title":"Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney","volume":"24","author":"Argani","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2019.04.002_bib0220","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/01.pas.0000213432.14740.14","article-title":"Desmoplastic small round cell tumor of the kidney in childhood","volume":"31","author":"Wang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2019.04.002_bib0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/PAS.0000000000000338","article-title":"Primary renal sclerosing epithelioid sarcoma. Report of 2 cases with EWSR1-CREB3L1 gene fusion","volume":"39","author":"Argani","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2019.04.002_bib0230","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/PAS.0000000000001098","article-title":"Clinicopathologic features of a series of primary renal CIC-rearranged sarcomas with comprehensive molecular analysis","volume":"42","author":"Mangray","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2019.04.002_bib0235","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1158\/1078-0432.CCR-14-2399","article-title":"Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma","volume":"21","author":"Hofvander","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2019.04.002_bib0240","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1158\/1078-0432.CCR-16-0290","article-title":"Recurrent TRIO fusion in nontranslocation-related sarcomas","volume":"23","author":"Delespaul","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2019.04.002_bib0245","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.urology.2010.09.028","article-title":"Adult renal sarcoma: clinical features and survival in a series of patients treated at a high-volume institution","volume":"77","author":"Wang","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.euo.2019.04.002_bib0250","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.eururo.2004.09.013","article-title":"Clinical characteristics and overall survival in genitourinary sarcomas treated with curative intent: a multicenter study","volume":"47","author":"Mondaini","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2019.04.002_bib0255","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.juro.2006.07.021","article-title":"Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience","volume":"176","author":"Dotan","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2019.04.002_bib0260","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood-2015-08-664649","article-title":"Integrated genomic DNA\/RNA profiling of hematologic malignancies in the clinical setting","volume":"127","author":"He","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.euo.2019.04.002_bib0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.euo.2019.04.002_bib0270","doi-asserted-by":"crossref","first-page":"e1005965","DOI":"10.1371\/journal.pcbi.1005965","article-title":"A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal","volume":"14","author":"Sun","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.euo.2019.04.002_bib0275","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/blood-2007-07-103697","volume":"112","author":"Ng","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.euo.2019.04.002_bib0280","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2019.04.002_bib0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0140-6736(16)30587-6","article-title":"Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial","volume":"388","author":"Tap","year":"2016","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.euo.2019.04.002_bib0290","first-page":"v573","article-title":"Co-amplification of KIT\/KDR\/PDGFRA in over 100,000 advanced cancer cases","volume":"28","author":"Disel","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2019.04.002_bib0295","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1200\/JCO.2005.03.2185","article-title":"Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme","volume":"23","author":"Reardon","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2019.04.002_bib0300","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1200\/JCO.2008.20.5054","article-title":"Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchical statistical model","volume":"27","author":"Chugh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2019.04.002_bib0305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1215\/15228517-2007-009","article-title":"Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme","volume":"9","author":"Holtkamp","year":"2007","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.euo.2019.04.002_bib0310","doi-asserted-by":"crossref","first-page":"e11858","DOI":"10.1371\/journal.pone.0011858","article-title":"The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment","volume":"5","author":"Zietsch","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2019.04.002_bib0315","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/PAS.0000000000000184","article-title":"Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas","volume":"38","author":"Neuville","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2019.04.002_bib0320","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ng.619","article-title":"Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy","volume":"42","author":"Barretina","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2019.04.002_bib0325","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1634\/theoncologist.2016-0310","article-title":"Clinical benefit in response to palbociclib treatment in refractory uterine leiomyosarcomas with a common CDKN2A alteration","volume":"22","author":"Elvin","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.euo.2019.04.002_bib0330","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.3747\/co.22.2700","article-title":"Does CDKN2A loss predict palbociclib benefit?","volume":"22","author":"Gao","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.euo.2019.04.002_bib0335","doi-asserted-by":"crossref","unstructured":"Shanmugam V, Griffin GK, Jacobsen ED, Fletcher CDM, Sholl LM, Hornick JL. Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. In press. https:\/\/doi.org\/10.1038\/s41379-018-0200-x.","DOI":"10.1038\/s41379-018-0200-x"},{"key":"10.1016\/j.euo.2019.04.002_bib0340","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2019.04.002_bib0345","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1155\/2013\/168145","article-title":"A pilot study of anti-CTLA4 antibody ipilimumab in patients with synovial sarcoma","volume":"2013","author":"Maki","year":"2013","journal-title":"Sarcoma"},{"key":"10.1016\/j.euo.2019.04.002_bib0350","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1002\/cncr.30738","article-title":"Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: results of a phase 2 study","volume":"123","author":"Ben-Ami","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2019.04.002_bib0355","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Genome Atlas Research Network. Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","author":"Cancer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.euo.2019.04.002_bib0360","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931119300446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931119300446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:48:13Z","timestamp":1762876093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931119300446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2588931119300446"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2019.04.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}